RE:CHRIS SAVILE
I appreciate your response. I am in NO WAY attempting to discredit Dr. Savile's merit, however... the C&P from Willow's website doesn't quite answer my question. I don't wish to scoff at their clarification. Moving to scale-up "ahead of initial expectations" great news!!!" Relocation of resources..." that's business "reduced head count..." sure. My concern is about the bigger picture. Willow is a Bioscience company, which is publicly traded in a burgeoning albeit very temperamental market space. These characteristics combined makes me all the more apprehensive about blindly accepting key management changes. Especially when my previous interpretation was that the incumbent was in part vital to the operation. I am NOT hinting that their is anything shady going on. I just know there is always more to the story.